StockWatch
·

Indivior Pharmaceuticals, Inc. Q3 FY25 Results

INDVQ3 FY25 Results
Filing
MetricValue ($ M)vs Q2 FY25
Revenue314.004.0%
Total Income314.004.0%
Expenditure271.0017.8%
PBT37.0040.3%
Net Profit42.00133.3%
OPM13.69%10.15pp
NPM13.38%7.42pp
EPS0.34126.7%
View full financials

Indivior PLC Reports Financial Results for Period Ended September 30, 2025

04 May 2026 · 4 May, 8:27 am

Summary

Indivior PLC issued a press release reporting its financial results for the period ended September 30, 2025. The company also posted presentation materials and updated its corporate presentation materials on its website on October 30, 2025.

Key Highlights

  1. 1

    Indivior PLC issued a press release reporting its financial results for the period ended September 30, 2025.

  2. 2

    The company posted presentation materials on its website on October 30, 2025.

  3. 3

    Indivior PLC updated its corporate presentation materials which are posted on its website.

Informational and educational content only. Not investment advice.